カテゴリ： Transparency Market Research, 世界, 医療/バイオ

世界の遠隔医療市場2022年ｰ2031年：コンポーネント別（ハードウェア、ソフトウェア、サービス）、サービスタイプ別

■ 英語タイトル：Telemedicine Market (Component Type: Hardware, Software, and Services; Service Type: Tele-consultation, Tele-monitoring, Tele-education, Tele-training, Tele-care, Tele-surgery, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031
	■ 発行会社/調査会社：Transparency Market Research ■ 商品コード：TMR23JA048 ■ 発行日：2022年10月26日 ■ 調査対象地域：グローバル ■ 産業分野：医療 ■ ページ数：350 ■ レポート言語：英語 ■ レポート形式：PDF ■ 納品方式：Eメール（受注後24時間以内）

■ 販売価格オプション（消費税別）

Single User（1名様閲覧）	USD5,795 ⇒換算￥869,250	見積依頼/購入/質問フォーム
Multi User（5名様閲覧）	USD8,795 ⇒換算￥1,319,250	見積依頼/購入/質問フォーム
Corporate License（法人閲覧）	USD11,795 ⇒換算￥1,769,250	見積依頼/購入/質問フォーム

※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Transparency Market Research社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[世界の遠隔医療市場2022年ｰ2031年：コンポーネント別（ハードウェア、ソフトウェア、サービス）、サービスタイプ別]についてメールでお問い合わせはこちら

*** レポート概要（サマリー）***

Transparency Market Research社は、世界の遠隔医療市場について調査し、序論、仮定・調査手法、市場概要、主要インサイト、コンポーネント別（ハードウェア、ソフトウェア、サービス）分析、専門分野別（皮膚科、婦人科、神経科、循環器内科、その他）分析、サービスタイプ別（遠隔診療、遠隔モニタリング、遠隔教育、遠隔トレーニング、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東/アフリカ）分析、競争状況、企業情報などの内容を掲載しています。なお、当書に掲載されている企業情報には、McKesson Corporationなどが含まれています。
・序論
・仮定・調査手法
・市場概要
・主要インサイト

・世界の遠隔医療市場規模：コンポーネント別
- ハードウェアの市場規模
- ソフトウェアの市場規模
- サービスの市場規模

・世界の遠隔医療市場規模：専門分野別
- 婦人科における市場規模
- 神経科における市場規模
- 循環器内科における市場規模
- その他専門分野における市場規模

・世界の遠隔医療市場規模：サービスタイプ別
- 遠隔診療の市場規模
- 遠隔モニタリングの市場規模
- 遠隔教育の市場規模
- 遠隔トレーニングの市場規模
- その他サービスタイプの市場規模

・世界の遠隔医療市場規模：地域別
- 北米の遠隔医療市場規模
- ヨーロッパの遠隔医療市場規模
- アジア太平洋の遠隔医療市場規模
- 中南米の遠隔医療市場規模
- 中東/アフリカの遠隔医療市場規模

・競争状況
・企業情報

Telemedicine Market – Scope of Report
TMR’s report on the global telemedicine market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global telemedicine market for the period 2017–2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global telemedicine market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the telemedicine market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global telemedicine market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global telemedicine market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global telemedicine market.

The report delves into the competitive landscape of the global telemedicine market. Key players operating in the global telemedicine market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global telemedicine market profiled in this report.

RESEARCH METHODOLOGY

The research methodology will be a combination of exhaustive primary and secondary research to analyze the market telemedicine.

Secondary Research

Secondary research includes a search of company literature, technical writing, patent data, Internet sources, and statistical data from government websites, trade associations, and agencies. This has proven to be the most reliable, effective, and successful approach for obtaining precise data, capturing industry participants’ insights, and recognizing business opportunities.

Secondary research sources that we typically refer, but are not limited to:

Company websites, presentations, annual reports, white papers, technical paper, product brochure
Internal and external proprietary databases and relevant patents
National government documents, statistical databases, and market reports
News articles, press releases, and webcasts specific to companies operating in the market

Specific Secondary Sources:

Industry Sources:
WorldWideScience.org
Elsevier, Inc.
National Institutes of Health (NIH)
PubMed
NCBI
Department of Health Care Service
Trade Data Sources
Trade Map
UN Comtrade
Trade Atlas
Company Information
OneSource Business Browser
Hoover’s
Factiva
Bloomberg
Mergers & Acquisitions
Thomson Mergers & Acquisitions
MergerStat
Profound

Primary Research

During the course of research, we conduct in-depth interviews and discussions with a wide range of key industry participants and opinion leaders. Primary research represents bulk of research efforts, supplemented by extensive secondary research.

We conduct primary interviews on the ongoing basis with industry participants and commentators to validate data and analysis. A typical research interview fulfills the following functions:

Provides first-hand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
Helps in validating and strengthening secondary research findings
Further develops the analysis team’s expertise and market understanding
Primary research involves e-mail interactions, telephonic interviews, as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies

Participants who typically take part in such a process include, but are not limited to:

Industry participants: Marketing/product managers, market intelligence managers, and regional sales managers
Purchasing/Sourcing managers, technical personnel, distributors
Outside experts: Investment bankers, valuation experts, and research analysts specializing in specific markets
Key opinion leaders specializing in different areas corresponding to different industry verticals

List of primary participants, but not limited to:

Advanced Oncotherapy PLC
Danfysik A/S
Hitachi, Ltd.
IBA Worldwide
Mevion Medical Systems, Inc.

Data Triangulation: Information culled from “Secondary & Primary Sources” is cross-checked with “TMR Knowledge Repository”, which is updated every quarter.

Market Estimation: Market size estimations involved in-depth study of product features, technology updates, geographic presence, product demand, sales data (value or volume), historical year-on-year growth, and others. Other approaches were also utilized to derive market size and forecasts. Where no hard data was available, we employed modeling techniques in order to produce comprehensive datasets. A rigorous methodology has been adopted, wherein the available hard data are cross-referenced with the following data types to produce estimates:

Demographic Data: Healthcare expenditure, inflation rates, and others
Industry Indicators: R&D investment, technology stage, and infrastructure, sector growth, and facilities

Market Forecasting: Market forecasts for various segments are derived taking into account drivers, restraints/challenges, and opportunities prevailing in the market and considering advantages/disadvantages of segments/sub-segments over other segments/sub-segments. Business environment, historical sales pattern, unmet needs, competitive intensity, and country-wise surgery data are some of the other pivotal factors, which are considered to derive market forecasts.

*** レポート目次（コンテンツ）***

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Telemedicine Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Telemedicine Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
4.5. Porter’s Five Force Analysis
5. Key Insights
5.1. Technological Advancements
5.2. Reimbursement Scenario by Region/globally
5.3. Key Industry Events (mergers, acquisitions, partnerships, collaborations, etc.)
5.4. COVID-19 Pandemic Impact on Industry (Value Chain and Short-/Mid-/Long-term impact)
6. Global Telemedicine Market Analysis and Forecast, by Component Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Component Type, 2017–2031
6.3.1. Hardware
6.3.2. Software
6.3.3. Service Type
6.4. Market Attractiveness Analysis, by Component Type
7. Global Telemedicine Market Analysis and Forecast, by Specialty Type
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Specialty Type, 2017–2031
7.3.1. Dermatology
7.3.2. Gynecology
7.3.3. Neurology
7.3.4. Cardiology
7.3.5. Orthopedics
7.3.6. Emergency Care
7.3.7. Internal Medicine
7.3.8. Others
7.4. Market Attractiveness Analysis, by Specialty Type
8. Global Telemedicine Market Analysis and Forecast, by Service Type
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by Service Type, 2017–2031
8.3.1. Tele-consultation
8.3.2. Tele-monitoring
8.3.3. Tele-education
8.3.4. Tele-training
8.3.5. Tele-care
8.3.6. Tele-surgery
8.3.7. Others
8.4. Market Attractiveness Analysis, by Service Type
9. Global Telemedicine Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Telemedicine Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Component Type, 2017–2031
10.2.1. Hardware
10.2.2. Software
10.2.3. Service Type
10.3. Market Value Forecast, by Specialty Type, 2017–2031
10.3.1. Dermatology
10.3.2. Gynecology
10.3.3. Neurology
10.3.4. Cardiology
10.3.5. Orthopedics
10.3.6. Emergency Care
10.3.7. Internal Medicine
10.3.8. Others
10.4. Market Value Forecast, by Service Type, 2017–2031
10.4.1. Tele-consultation
10.4.2. Tele-monitoring
10.4.3. Tele-education
10.4.4. Tele-training
10.4.5. Tele-care
10.4.6. Tele-surgery
10.4.7. Others
10.5. Market Value Forecast, by Country, 2017–2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Component Type
10.6.2. By Specialty Type
10.6.3. By Service Type
10.6.4. By Country
11. Europe Telemedicine Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Component Type, 2017–2031
11.2.1. Hardware
11.2.2. Software
11.2.3. Service Type
11.3. Market Value Forecast, by Specialty Type, 2017–2031
11.3.1. Dermatology
11.3.2. Gynecology
11.3.3. Neurology
11.3.4. Cardiology
11.3.5. Orthopedics
11.3.6. Emergency Care
11.3.7. Internal Medicine
11.3.8. Others
11.4. Market Value Forecast, by Service Type, 2017–2031
11.4.1. Tele-consultation
11.4.2. Tele-monitoring
11.4.3. Tele-education
11.4.4. Tele-training
11.4.5. Tele-care
11.4.6. Tele-surgery
11.4.7. Others
11.5. Market Value Forecast, by Country/Sub-region, 2017–2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Component Type
11.6.2. By Specialty Type
11.6.3. By Service Type
11.6.4. By Country/Sub-region
12. Asia Pacific Telemedicine Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Component Type, 2017–2031
12.2.1. Hardware
12.2.2. Software
12.2.3. Service Type
12.3. Market Value Forecast, by Specialty Type, 2017–2031
12.3.1. Dermatology
12.3.2. Gynecology
12.3.3. Neurology
12.3.4. Cardiology
12.3.5. Orthopedics
12.3.6. Emergency Care
12.3.7. Internal Medicine
12.3.8. Others
12.4. Market Value Forecast, by Service Type, 2017–2031
12.4.1. Tele-consultation
12.4.2. Tele-monitoring
12.4.3. Tele-education
12.4.4. Tele-training
12.4.5. Tele-care
12.4.6. Tele-surgery
12.4.7. Others
12.5. Market Value Forecast, by Country/Sub-region, 2017–2031
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Component Type
12.6.2. By Specialty Type
12.6.3. By Service Type
12.6.4. By Country/Sub-region
13. Latin America Telemedicine Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Component Type, 2017–2031
13.2.1. Hardware
13.2.2. Software
13.2.3. Service Type
13.3. Market Value Forecast, by Specialty Type, 2017–2031
13.3.1. Dermatology
13.3.2. Gynecology
13.3.3. Neurology
13.3.4. Cardiology
13.3.5. Orthopedics
13.3.6. Emergency Care
13.3.7. Internal Medicine
13.3.8. Others
13.4. Market Value Forecast, by Service Type, 2017–2031
13.4.1. Tele-consultation
13.4.2. Tele-monitoring
13.4.3. Tele-education
13.4.4. Tele-training
13.4.5. Tele-care
13.4.6. Tele-surgery
13.4.7. Others
13.5. Market Value Forecast, by Country/Sub-region, 2017–2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Component Type
13.6.2. By Specialty Type
13.6.3. By Service Type
13.6.4. By Country/Sub-region
14. Middle East & Africa Telemedicine Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Component Type, 2017–2031
14.2.1. Hardware
14.2.2. Software
14.2.3. Service Type
14.3. Market Value Forecast, by Specialty Type, 2017–2031
14.3.1. Dermatology
14.3.2. Gynecology
14.3.3. Neurology
14.3.4. Cardiology
14.3.5. Orthopedics
14.3.6. Emergency Care
14.3.7. Internal Medicine
14.3.8. Others
14.4. Market Value Forecast, by Service Type, 2017–2031
14.4.1. Tele-consultation
14.4.2. Tele-monitoring
14.4.3. Tele-education
14.4.4. Tele-training
14.4.5. Tele-care
14.4.6. Tele-surgery
14.4.7. Others
14.5. Market Value Forecast, by Country/Sub-region, 2017–2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Component Type
14.6.2. By Specialty Type
14.6.3. By Service Type
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player – Competition Matrix (by tier and size of companies)
15.2. Company Profiles
15.2.1. Agfa-Gevaert Group
15.2.1.1. Overview (HQ, Employee Strength, Business Segments)
15.2.1.2. Financials
15.2.1.3. Recent Developments
15.2.1.4. Strategy
15.2.2. AMD Global Telemedicine
15.2.2.1. Overview (HQ, Employee Strength, Business Segments)
15.2.2.2. Financials
15.2.2.3. Recent Developments
15.2.2.4. Strategy
15.2.3. CISCO Systems, Inc.
15.2.3.1. Overview (HQ, Employee Strength, Business Segments)
15.2.3.2. Financials
15.2.3.3. Recent Developments
15.2.3.4. Strategy
15.2.4. F. Hoffmann-La Roche Ltd.
15.2.4.1. Overview (HQ, Employee Strength, Business Segments)
15.2.4.2. Financials
15.2.4.3. Recent Developments
15.2.4.4. Strategy
15.2.5. Honeywell HomMed LLC
15.2.5.1. Overview (HQ, Employee Strength, Business Segments)
15.2.5.2. Financials
15.2.5.3. Recent Developments
15.2.5.4. Strategy
15.2.6. InTouch Technologies, Inc.
15.2.6.1. Overview (HQ, Employee Strength, Business Segments)
15.2.6.2. Financials
15.2.6.3. Recent Developments
15.2.6.4. Strategy
15.2.7. BioTelemetry, Inc.
15.2.7.1. Overview (HQ, Employee Strength, Business Segments)
15.2.7.2. Financials
15.2.7.3. Recent Developments
15.2.7.4. Strategy
15.2.8. Medtronic
15.2.8.1. Overview (HQ, Employee Strength, Business Segments)
15.2.8.2. Financials
15.2.8.3. Recent Developments
15.2.8.4. Strategy
15.2.9. OBS Medical Ltd.
15.2.9.1. Overview (HQ, Employee Strength, Business Segments)
15.2.9.2. Financials
15.2.9.3. Recent Developments
15.2.9.4. Strategy
15.2.10. Siemens Healthcare Private Limited
15.2.10.1. Overview (HQ, Employee Strength, Business Segments)
15.2.10.2. Financials
15.2.10.3. Recent Developments
15.2.10.4. Strategy
15.2.11. McKesson Corporation
15.2.11.1. Overview (HQ, Employee Strength, Business Segments)
15.2.11.2. Financials
15.2.11.3. Recent Developments
15.2.11.4. Strategy

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/

H&I Global Research

世界の遠隔医療市場2022年ｰ2031年：コンポーネント別（ハードウェア、ソフトウェア、サービス）、サービスタイプ別

グローバル市場調査会社